Navigation Links
BioMS Medical announces its intention to renew a normal course issuer bid
Date:8/20/2007

8, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. For further information please visit our website at http://www.biomsmedical.com.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that MBP8298 will continue to demonstrate a safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE BioMS Medical Corp.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... On Track to File NDA with FDA in Early to Mid-20...wire-FirstCall/ -- Strativa Pharmaceuticals, the p... Companies, Inc. (NYSE: PRX ) today announced th...he successful completion of all pivotal bioequival...etron. The ondansetron thin film product is being ...
(Date:12/2/2008)... ST. JOSEPH, Mich., Dec. 2 GeneGo... announced today that Burnham has become a certifi...s will have institution-wide access to GeneGo,s Me...support. The Burnham institute is a world-class b... experimental studies throughout many departments,...
(Date:12/2/2008)... TIRAT CARMEL, Israel, December 2 /PRNewswire...ications show that Magnetic Resonance-guided Focus...m has the potential to be an,effective noninvasiv...read to,the bones (bone metastases). The results ...nline issue of Annals of Surgical Oncology, while ...
(Date:12/2/2008)... SOPHIA ANTIPOLIS, France, December 2 /PRNews...s: COX) today announced it has signed an agreement...ly of naproxcinod drug substance,(or API, active ...lead,investigational product and the first compou...Donating (CINOD) class of,anti-inflammatory agent...
Breaking Biology Technology:Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 3New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 4NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4
...ws.com) - Wisconsin Right to Life this week launch...human cloning. "Whether we are talking about cloni...uman embryos for the express purpose of destroying... a threat to the sanctity of human life," said Sus...ght to Life. , ,The petition drive, to be conduct...
...arch Foundation is in the top six nationally in li...s. In 2001, UW-Madison ranked 11th out of 143 U.S....e collected on university discoveries. Recent meas...ent growth and number of companies nationally. Wis...vironment for biotechnology firms with over 200 co...
...Samyog Software Limited , discusses with the Wisco...hodologies for companies contemplating offshore ou...lutions - intranets, extranets, B2B e-business, B2...s. Their solutions may be either custom built or c...What is Samyog Softwares background? , , Murali I...
...nic newsletter is like giving out your phone numbe... what you want. Sometimes you never hear from them...ou. , ,They are the blind date from hell. You are...lephone sales pitches highlighting how wonderful, .... They talk, talk and talk hoping that their volum...
Other Biology Technology:Anti-Cloning Petition Drive Launched in Wisconsin 2TAKING WISCONSINS BIOTECH MESSAGE TO THE WORLD 2TAKING WISCONSINS BIOTECH MESSAGE TO THE WORLD 3Lessons in Offshore Software Development 2Lessons in Offshore Software Development 3Lessons in Offshore Software Development 4Lessons in Offshore Software Development 5Quantity versus Quality: Effective E-Marketing Relationships 2Quantity versus Quality: Effective E-Marketing Relationships 3
(Date:12/2/2008)... This release is available in German . , ,...d model-making tricks. Scientists at the Max Planc... Stuttgart and the Colorado School of Mines have c... model makers use to get ships into a bottle where... erected until it is in the bottle. In the same wa...
(Date:12/2/2008)... LOS ANGELES, Calif. Dec. 2, 2008 Presbycusis, o...t of all hearing loss. So, why do some people los... can still hear a pin drop? , The answer may b... Molecular Genetics . Advance access is available ...nt.dtl . , "This is the first ever and larges...
(Date:12/1/2008)... BINGHAMTON, NY -- By discovering the meaning of a...imates, Binghamton University geologist Tim Lowens...nderstand what we,re probably in for over the next...up the heat and, ultimately, to change life as we...ifferent place in the next hundred years or so, an...
(Date:12/1/2008)..., The National Academy of Sciences will hold a co...y studies of the nature of niches of organisms. Le...ols to predict future patterns of distribution and...paleontology, phylogenetics, and biodiversity info.... Part of the Sackler Colloquium series, the event...
Breaking Biology News(10 mins):Ship-in-a-bottle kit on a microchip 2Ship-in-a-bottle kit on a microchip 3House Ear Institute, TGen and Belgian researchers identify gene in age-related hearing loss 2Foretelling a major meltdown 2Foretelling a major meltdown 3Crowell 26 Morings Expanding Health Care Litigation Practice Gains Experienced Litigator 3136 1Crowell 26 Morings Expanding Health Care Litigation Practice Gains Experienced Litigator 3136 2Crowell 26 Morings Expanding Health Care Litigation Practice Gains Experienced Litigator 3136 3Inverness Medical Innovations Agrees to Acquire Panbio Ltd 1130 1Inverness Medical Innovations Agrees to Acquire Panbio Ltd 1130 2Depression can foreshadow intellectual decline in older people 3132 1Depression can foreshadow intellectual decline in older people 3132 2Gene targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine 715 1Gene targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine 715 2Gene targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine 715 3
...alian egg ultimately develops into a male or femal...een two different genes encoding signaling protein...ng to a new study led by Duke University Medical C...ice, the researchers found that two specific genes... stages of development in the mammalian gonad befo...
...jects to operate a robot-controlled joystick, John...he brain "learns" to control certain muscle moveme...over the long haul. The results, the investigators...ople who have lost motor abilities to brain injuri... May 23 issue of PLoS Biology, the researchers bui...
...jects to operate a robot-controlled joystick, John...he brain "learns" to control certain muscle moveme...over the long haul. The results, the investigators...ople who have lost motor abilities to brain injuri... May 23 issue of PLoS Biology, the researchers bui...
...r,s northeast coast have so far resisted the damag...d to global climate change, say scientists who rec...usly unexplored region in March 2006 by scientists...documented a much greater variety of life than exp...science and 17 others noted for the first time in ...
Other Biology News:Genetic tug of war determines sexual differentiation 2Genetic tug of war determines sexual differentiation 3New approach to vaccine development provides potent, long-lasting immunity 2New approach to vaccine development provides potent, long-lasting immunity 3Robotic joystick reveals how brain controls movement 2Robotic joystick reveals how brain controls movement 3Healthy coral reefs of Madagascar resisting damage from climate change 2
Attoglow Western Blot Enhancing Kit contains Millennium Enhancer which can significantly boost Western blot signals, and is compatible with other enhancing mechanisms to achieve multiplied enhancing
Immunogen: Synthetic peptide: S(399) P W S E L E F Q F P D D K D P V W E F(418) Storage: -20 C, Avoid Freeze/Thaw Cycles
GolgiPlug from BD Biosciences Pharmingen
Standard 2" and 3" Fiberboard Boxes can be sold separately or with 16, 25, 36, 49, 64, 81 or 100 cell dividers. Fiberboard boxes can also be ordered with corresponding freezer racks
Biology Products: